| Identification | Back Directory | [Name]
5,7-DIHYDROXYCOUMARIN | [CAS]
2732-18-5 | [Synonyms]
5,7-DIHYDROXYCOUMARIN
5,7-dihydroxychromen-2-one
5,7-Dihydroxy-2H-chromen-2-one
5,7-dihydroxy-1-benzopyran-2-one
5,7-Dihydroxy-2H-1-benzopyran-2-one
2H-1-Benzopyran-2-one, 5,7-dihydroxy- | [Molecular Formula]
C9H6O4 | [MDL Number]
MFCD00488354 | [MOL File]
2732-18-5.mol | [Molecular Weight]
178.14 |
| Chemical Properties | Back Directory | [Melting point ]
280 °C | [Boiling point ]
506.4±19.0 °C(Predicted) | [density ]
1.563±0.06 g/cm3(Predicted) | [storage temp. ]
Inert atmosphere,2-8°C | [form ]
Solid | [pka]
7.18±0.20(Predicted) | [color ]
Off-white to yellow |
| Hazard Information | Back Directory | [Uses]
5,7-Dihydroxy-2H-chromen-2-one can be used to prepare UV-?responsive coumarin controlled release and self-?repairing antifouling paint. | [Synthesis Reference(s)]
Journal of Medicinal Chemistry, 41, p. 4542, 1998 DOI: 10.1021/jm981032o
Journal of Heterocyclic Chemistry, 2, p. 91, 1965 DOI: 10.1002/jhet.5570020116 | [Synthesis]
The general procedure for the synthesis of 5,7-dihydroxy-2H-benzopyran-2-one from resorcinol and propargyl acid was as follows: a mixture of resorcinol (1.0 mmol), propargyl acid (1.1 mmol), and Yb(OTf)3 hydrate (0.1 mmol) was placed in an open reaction vessel in a microwave reaction unit and irradiated for 2 min at 200 W (80 °C) . The reaction process was monitored by thin layer chromatography (TLC) and the eluent was CH2Cl2/MeOH (99:1). Upon completion of the reaction, the crude product was diluted with ether (Et2O) and the suspension formed was filtered under vacuum to isolate the catalyst and the precipitate was washed with ether several times. The filtrate was washed twice sequentially with 5% NaHCO3 solution (10 mL), dried over anhydrous MgSO4 and evaporated to dryness under vacuum to afford the target product 5,7-dihydroxy-2H-benzopyran-2-one. | [storage]
4°C, stored under nitrogen | [References]
[1] Synlett, 1999, # 5, p. 608 - 610
[2] Tetrahedron Letters, 2016, vol. 57, # 26, p. 2939 - 2942
[3] Synthesis, 2011, # 8, p. 1283 - 1289
[4] Journal of Natural Medicines, 2017, vol. 71, # 4, p. 735 - 744 |
|
|